Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis
M. Gironi(Don Carlo Gnocchi Foundation), Mauro Bozzola(University of Pavia), Lorenza Montagna(University of Pavia), Raffaello Nemni(University of Milan), Claudio Solaro(Rina Services (Italy)), Riccardo Albertini(Policlinico San Matteo Fondazione), Cristina Meazza(University of Pavia), A. P. Batocchi(Casa Sollievo della Sofferenza), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Massimo Vaghi(Unknown), Marco Rovaris(San Raffaele University of Rome)
Cited by 14
Related Papers
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Elevated Plasma Vitamin B12 Concentrations Are Independent Predictors of In-Hospital Mortality in Adult Patients at Nutritional Risk
|Nutrients|2016|393